Related Experiment Video
Updated: Dec 20, 2025

Murine Oropharyngeal Aspiration Model of Ventilator-associated and Hospital-acquired Bacterial Pneumonia
Published on: June 28, 2018
Pathogenesis-Targeted Preventive Strategies for Multidrug Resistant Ventilator-Associated Pneumonia: A Narrative
Antonella Cotoia1, Savino Spadaro2, Guido Gambetti1
1Department of Anesthesia and Intensive Care, University of Foggia, Azienda Ospedaliero-Universitaria Ospedali Riuniti, Viale Pinto 241, 71122 Foggia, Italy.
Abstract:
Ventilator-associated pneumonia (VAP) is the most common hospital-acquired infection in the intensive care unit (ICU), accounting for relevant morbidity and mortality among critically ill patients, especially when caused by multidrug resistant (MDR) organisms. The rising problem of MDR etiologies, which has led to a reduction in treatment options, have increased clinician's attention to the employment of effective prevention strategies. In this narrative review we summarized the evidence resulting from 27 original articles that were identified through a systematic database search of the last 15 years, focusing on several pathogenesis-targeted strategies which could help preventing MDR-VAP. Oral hygiene with Chlorhexidine (CHX), CHX body washing, selective oral decontamination (SOD) and/or digestive decontamination (SDD), multiple decontamination regimens, probiotics, subglottic secretions drainage (SSD), special cuff material and shape, silver-coated endotracheal tubes (ETTs), universal use of gloves and contact isolation, alcohol-based hand gel, vaporized hydrogen peroxide, and bundles of care have been addressed. The most convincing evidence came from interventions directly addressed against the key factors of MDR-VAP pathogenesis, especially when they are jointly implemented into bundles. Further research, however, is warranted to identify the most effective combination.
Insights
Preventing multidrug-resistant ventilator-associated pneumonia (MDR-VAP) in ICUs requires targeted strategies. Bundling interventions like oral care and decontamination shows promise in reducing these infections and improving patient outcomes.
Area of Science:
- Critical Care Medicine
- Infectious Diseases
- Hospital Epidemiology
Background:
- Ventilator-associated pneumonia (VAP) is a leading hospital-acquired infection in ICUs, associated with significant morbidity and mortality.
- The increasing prevalence of multidrug-resistant (MDR) organisms complicates VAP treatment, necessitating effective prevention strategies.
Purpose of the Study:
- To review and summarize evidence on pathogenesis-targeted strategies for preventing MDR-VAP.
- To identify interventions with the most convincing evidence for MDR-VAP prevention.
Main Methods:
- Systematic database search of 27 original articles published within the last 15 years.
- Narrative review focusing on strategies targeting key factors in MDR-VAP pathogenesis.
Main Results:
- Multiple prevention strategies were evaluated, including oral hygiene (Chlorhexidine), decontamination regimens (SOD/SDD), probiotics, subglottic secretion drainage, and specialized endotracheal tubes.
- Interventions directly targeting MDR-VAP pathogenesis, particularly when implemented as bundles of care, demonstrated the most compelling evidence.
Conclusions:
- Bundled interventions addressing key pathogenic factors are most effective in preventing MDR-VAP.
- Further research is needed to determine optimal combinations of these strategies for maximum efficacy.
More Related Videos
Related Concept Videos
Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia II: Pathophysiology
Transmission-based Precautions II: Airborne and Protective Environment
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
Pneumonia III: Complications and Assessment

